دورية أكاديمية
أعرض في EDS

Motivators and Demotivators for COVID-19 Vaccination Based on Co-Occurrence Networks of Verbal Reasons for Vaccination Acceptance and Resistance: Repetitive Cross-Sectional Surveys and Network Analysis.

التفاصيل البيبلوغرافية
العنوان: Motivators and Demotivators for COVID-19 Vaccination Based on Co-Occurrence Networks of Verbal Reasons for Vaccination Acceptance and Resistance: Repetitive Cross-Sectional Surveys and Network Analysis.
المؤلفون: Liao Q; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong)., Yuan J; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong)., Wong IOL; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong).; World Health Organization Collaborating Center for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong)., Ni MY; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong).; State Key Laboratory of Brain and Cognitive Sciences, University of Hong Kong, Hong Kong, China (Hong Kong).; Urban Systems Institute, University of Hong Kong, Hong Kong, China (Hong Kong)., Cowling BJ; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong).; World Health Organization Collaborating Center for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong).; Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong, China (Hong Kong)., Lam WWT; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong).; Jockey Club Institute of Cancer Care, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China (Hong Kong).
المصدر: JMIR public health and surveillance [JMIR Public Health Surveill] 2024 Apr 22; Vol. 10, pp. e50958. Date of Electronic Publication: 2024 Apr 22.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101669345 Publication Model: Electronic Cited Medium: Internet ISSN: 2369-2960 (Electronic) Linking ISSN: 23692960 NLM ISO Abbreviation: JMIR Public Health Surveill Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Toronto : JMIR Publications, [2015]-
مواضيع طبية MeSH: Motivation* , Vaccination Hesitancy*/psychology , Vaccination Hesitancy*/statistics & numerical data , COVID-19 Vaccines*/administration & dosage , COVID-19*/prevention & control , COVID-19*/psychology, Humans ; Cross-Sectional Studies ; Male ; Female ; Adult ; Hong Kong ; Middle Aged ; Adolescent ; Aged ; Young Adult ; Surveys and Questionnaires
مستخلص: Background: Vaccine hesitancy is complex and multifaced. People may accept or reject a vaccine due to multiple and interconnected reasons, with some reasons being more salient in influencing vaccine acceptance or resistance and hence the most important intervention targets for addressing vaccine hesitancy.
Objective: This study was aimed at assessing the connections and relative importance of motivators and demotivators for COVID-19 vaccination in Hong Kong based on co-occurrence networks of verbal reasons for vaccination acceptance and resistance from repetitive cross-sectional surveys.
Methods: We conducted a series of random digit dialing telephone surveys to examine COVID-19 vaccine hesitancy among general Hong Kong adults between March 2021 and July 2022. A total of 5559 and 982 participants provided verbal reasons for accepting and resisting (rejecting or hesitating) a COVID-19 vaccine, respectively. The verbal reasons were initially coded to generate categories of motivators and demotivators for COVID-19 vaccination using a bottom-up approach. Then, all the generated codes were mapped onto the 5C model of vaccine hesitancy. On the basis of the identified reasons, we conducted a co-occurrence network analysis to understand how motivating or demotivating reasons were comentioned to shape people's vaccination decisions. Each reason's eigenvector centrality was calculated to quantify their relative importance in the network. Analyses were also stratified by age group.
Results: The co-occurrence network analysis found that the perception of personal risk to the disease (egicentrality=0.80) and the social responsibility to protect others (egicentrality=0.58) were the most important comentioned reasons that motivate COVID-19 vaccination, while lack of vaccine confidence (egicentrality=0.89) and complacency (perceived low disease risk and low importance of vaccination; egicentrality=0.45) were the most important comentioned reasons that demotivate COVID-19 vaccination. For older people aged ≥65 years, protecting others was a more important motivator (egicentrality=0.57), while the concern about poor health status was a more important demotivator (egicentrality=0.42); for young people aged 18 to 24 years, recovering life normalcy (egicentrality=0.20) and vaccine mandates (egicentrality=0.26) were the more important motivators, while complacency (egicentrality=0.77) was a more important demotivator for COVID-19 vaccination uptake.
Conclusions: When disease risk is perceived to be high, promoting social responsibility to protect others is more important for boosting vaccination acceptance. However, when disease risk is perceived to be low and complacency exists, fostering confidence in vaccines to address vaccine hesitancy becomes more important. Interventions for promoting vaccination acceptance and reducing vaccine hesitancy should be tailored by age.
(©Qiuyan Liao, Jiehu Yuan, Irene Oi Ling Wong, Michael Yuxuan Ni, Benjamin John Cowling, Wendy Wing Tak Lam. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 22.04.2024.)
References: Hum Vaccin Immunother. 2021 Nov 2;17(11):4015-4020. (PMID: 34353226)
Vaccine. 2022 Apr 6;40(16):2379-2387. (PMID: 35305828)
JAMA. 2022 Jan 18;327(3):211-212. (PMID: 34989789)
PLoS One. 2021 Nov 17;16(11):e0258462. (PMID: 34788308)
Emerg Microbes Infect. 2022 Dec;11(1):1072-1078. (PMID: 35348429)
NPJ Vaccines. 2022 Oct 1;7(1):114. (PMID: 36182929)
MMWR Morb Mortal Wkly Rep. 2022 Apr 15;71(15):545-548. (PMID: 35421076)
Curr Opin Psychol. 2022 Feb;43:307-311. (PMID: 34517200)
Soc Psychol Personal Sci. 2017 Jul;8(5):528-537. (PMID: 28919944)
J Gerontol B Psychol Sci Soc Sci. 2023 Apr 1;78(4):736-748. (PMID: 36416594)
Nat Commun. 2021 Jan 4;12(1):29. (PMID: 33397962)
Nat Med. 2020 Aug;26(8):1205-1211. (PMID: 32546824)
BMJ Open. 2021 Jun 15;11(6):e048172. (PMID: 34130963)
Lancet. 2022 Aug 13;400(10351):535-538. (PMID: 35817078)
Health Psychol Behav Med. 2018 Sep 25;6(1):301-328. (PMID: 34040834)
Health Promot Int. 2022 Feb 17;37(1):. (PMID: 34244738)
Hum Vaccin Immunother. 2023 Dec 31;19(1):2166323. (PMID: 36951564)
Nat Med. 2023 Mar;29(3):623-631. (PMID: 36720270)
BMJ Glob Health. 2021 Feb;6(2):. (PMID: 33597280)
JAMA. 2021 Feb 9;325(6):532-533. (PMID: 33372955)
J Affect Disord. 2022 Jan 15;297:301-308. (PMID: 34715181)
Lancet Reg Health West Pac. 2022 Mar 29;23:100441. (PMID: 35359914)
Lancet Public Health. 2020 May;5(5):e279-e288. (PMID: 32311320)
NPJ Vaccines. 2022 Aug 17;7(1):96. (PMID: 35977958)
Vaccine. 2021 Jun 11;39(26):3520-3527. (PMID: 34023136)
J Community Health. 2022 Apr;47(2):237-245. (PMID: 34687388)
JAMA. 2021 Aug 24;326(8):766-767. (PMID: 34213530)
Vaccine. 2019 Jul 9;37(30):4124-4132. (PMID: 31186189)
PLoS One. 2018 Dec 7;13(12):e0208601. (PMID: 30532274)
Curr Psychol. 2022 Sep 7;:1-16. (PMID: 36090914)
BMJ Glob Health. 2022 May;7(5):. (PMID: 35618306)
N Engl J Med. 2022 Apr 21;386(16):1532-1546. (PMID: 35249272)
Front Psychol. 2018 Sep 19;9:1742. (PMID: 30283387)
Vaccine. 2019 Jul 26;37(32):4454-4459. (PMID: 31277956)
Emerg Microbes Infect. 2023 Dec;12(1):2149935. (PMID: 36398721)
Vaccine. 2015 Aug 14;33(34):4161-4. (PMID: 25896383)
Int J Nurs Stud. 2022 Jul;131:104241. (PMID: 35489108)
J Adv Nurs. 2022 Sep;78(9):2904-2915. (PMID: 35441742)
Health Sci Rep. 2022 Feb 09;5(2):e485. (PMID: 35155827)
Science. 2021 Nov 12;374(6569):879-882. (PMID: 34618594)
Vaccines (Basel). 2022 Jul 20;10(7):. (PMID: 35891318)
Lancet Reg Health Am. 2022 Apr;8:100205. (PMID: 35229080)
Nat Hum Behav. 2021 Jul;5(7):947-953. (PMID: 33972767)
Vaccine. 2023 Feb 17;41(8):1490-1495. (PMID: 36707338)
Lancet Reg Health West Pac. 2023 Apr 10;36:100752. (PMID: 37547048)
Vaccines (Basel). 2021 May 17;9(5):. (PMID: 34067682)
BMJ Open. 2019 Dec 11;9(12):e033245. (PMID: 31831547)
Vaccines (Basel). 2021 Sep 28;9(10):. (PMID: 34696208)
Sci Rep. 2021 Nov 18;11(1):22480. (PMID: 34795312)
JAMA Netw Open. 2022 Sep 1;5(9):e2232760. (PMID: 36136332)
J Commun Healthc. 2023 Oct;16(3):298-303. (PMID: 37115094)
Nat Med. 2022 Feb;28(2):232-235. (PMID: 35022575)
Proc Natl Acad Sci U S A. 2021 Aug 10;118(32):. (PMID: 34315824)
J Psychiatr Res. 2023 Apr;160:180-186. (PMID: 36809746)
Sci Adv. 2021 Feb 3;7(6):. (PMID: 33536223)
EClinicalMedicine. 2021 Oct;40:101113. (PMID: 34490416)
J Affect Disord Rep. 2022 Apr;8:100345. (PMID: 35382495)
Vaccine. 2020 Nov 17;38(49):7789-7798. (PMID: 33109389)
Public Health. 2022 Oct;211:88-96. (PMID: 36058200)
فهرسة مساهمة: Keywords: COVID-19; co-occurrence network analysis; motivators; vaccination acceptance; vaccine hesitancy
المشرفين على المادة: 0 (COVID-19 Vaccines)
تواريخ الأحداث: Date Created: 20240422 Date Completed: 20240429 Latest Revision: 20240509
رمز التحديث: 20240509
مُعرف محوري في PubMed: PMC11074890
DOI: 10.2196/50958
PMID: 38648099
قاعدة البيانات: MEDLINE
الوصف
تدمد:2369-2960
DOI:10.2196/50958